| 000 | 01538 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516210327.0 | ||
| 264 | 0 | _c20150513 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1437-160X | ||
| 024 | 7 |
_a10.1007/s00296-014-3020-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoghdadi, Ghada | |
| 245 | 0 | 0 |
_aIncreased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. _h[electronic resource] |
| 260 |
_bRheumatology international _cSep 2014 |
||
| 300 |
_a1217-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 |
_aInterferon-gamma _xblood |
| 650 | 0 | 4 |
_aInterleukin-17 _xblood |
| 650 | 0 | 4 |
_aInterleukin-4 _xblood |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Ligand Superfamily Member 13 _xblood |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aElewa, Enass A | |
| 773 | 0 |
_tRheumatology international _gvol. 34 _gno. 9 _gp. 1217-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00296-014-3020-4 _zAvailable from publisher's website |
| 999 |
_c23752491 _d23752491 |
||